MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
Optec International, Inc. engages in the distribution of LED solar lighting systems, personal protective equipment, and related healthcare products. Its products include OPTEC Fuel Maximizer, OPTEC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback